DRUG DELIVERY SYSTEM

这个子项目是利用由NIH/NCRR资助的中心拨款提供的资源的许多研究子项目之一。子项目和调查员(PI)可能从另一个NIH来源获得了主要资金，因此可能会出现在其他CRISE条目中。列出的机构是针对中心的，而不一定是针对调查员的机构。这项申请的长期目标是加强制药领域的基础设施。药剂学药物递送研究活动的开展将有助于实现这项提议的目标，其中包括：a)发展关键研究领域，这将促进药学学院不同科学家之间的跨学科研究环境。选定的关键领域之一是癌症，特别强调肺癌；(B)通过雇用关键人员加强药剂科，以培养足够数量的现役研究人员；(C)提供机会，培训少数族裔科学家在药物配制和给药领域；以及(D)利用市场上各种新的配方和药物输送工具，为社区提供教育支持。上述目标的成功完成将使药剂学学院能够在受控药物输送的广泛领域建立各种重点领域，并使该部门能够吸引新的教师，同时促进与FAMU药学院的药物化学家和药理学家的合作。此外，该中心的建立将使教师能够产生初步数据，以竞争R01资金；开发治疗肺癌的新吸入系统；并促进与即将成立的FSU医学院和生物医学工程系的合作。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long-term objective of this application is to strengthen the infrastructure in the area of Pharmaceutics. The development of a drug delivery research activity in Pharmaceutics will facilitate the objectives of this proposal which include: a) develop key research areas which will foster an environment of inter and intradisciplinary research among various scientists at the College of Pharmacy. One of the key areas chosen is cancer with special emphasis on lung cancer; b) strengthen the Pharmaceutics division by the hiring of key personnel required to build a critical mass of active researchers; c) provide opportunities for the training of minority scientists in the area of drug formulation and delivery; and d) provide educational support for the community with the various new formulations and drug delivery devices on the market. The successful completion of the above listed objectives will enable the pharmaceutics faculty to build various focus areas in the broad area of controlled drug delivery and enable the division to attract new faculty along with facilitating collaboration with medicinal chemists and pharmacologists at the FAMU College of Pharmacy. Furthermore, the establishment of this center will allow the faculty to generate preliminary data to compete for R01 funding; develop novel inhalation systems for the treatment of lung cancer; and facilitate collaboration with the upcoming FSU medical school and biomedical engineering department.